30.00
+0.75
(2.56%)
May 24 - Close
BOM
real-time data -
Disclaimer
Currency in INR
| Range | 30.00 - 30.00 |
| 52 week | 20.30 - 42.05 |
| Open | 30.00 |
| Vol. | 10.00 |
| Mkt cap | 1.03B |
| P/E | 90.74 |
| Div/yield | - |
| EPS | 0.33 |
| Shares | 34.43M |
| Beta | - |
| Inst. own | - |
Events
May 27, 2013
Q4 2013 Zenotech Laboratories Ltd Earnings Release
May 13, 2013
Q3 2012 Zenotech Laboratories Ltd Earnings Release
|
|
Key stats and ratios
| Q1 (Mar '07) | 2011 | |
| Net profit margin | 13.86% | -481.11% |
| Operating margin | -6.18% | -481.11% |
| EBITD margin | - | -389.42% |
| Return on average assets | - | -23.17% |
| Return on average equity | - | -25.08% |
| Carbon Disclosure Rating | - | - |
Address
4th Floor, Road No. 2, Park View Estate
HYDERABAD, 500 073
India
+91-40-23540994 (Phone)
+91-40-23555465 (Fax)
HYDERABAD, 500 073
India
+91-40-23540994 (Phone)
+91-40-23555465 (Fax)
Website links
External links
Discussion Group - Google Finance
Advertisement
Description
Zenotech Laboratories Limited develops and manufactures generic biopharmaceuticals and markets them to people with unmet medical needs worldwide. The Company is engaged in the manufacture and trading of Pharmaceuticals in India. The Company�s injectables product portfolio primarily serves therapy areas, such as oncology and anesthesiologyAs of March 31, 2012, the Company licensed capacity per annum included Pharmaceutical formulations is 800,000 Injectable Numbers; Lyophalized & liquid injections is 400,000 Capsule Numbers; Tablets and capsules is 1,000,000 tablet numbers; Granulocyte Colony Stimulating Factor (G-CSF) is 200 grams; Granulocyte Macrophage Colony Stimulating Factor (G-MCSF) is 100 grams, and Interleukin - II (IL-2) is 100 grams. The Company�s subsidiaries include Zenotech Farmaceutica Do Brasil Ltda, Zenotech Laboratories Nigeria Ltd and Zenotech Inc.
Officers and directors
| Bimal Kishore Raizada | Managing Director, Executive Director | |
| I. Srinivas | Company Secretary | |
| Sudershan K. Arora | Non-Executive Non-Independent Chairman of the Board | |
| Ranbir S. Bakshi | Non-Executive Independent Director | |
| N. K. Ganguly | Non-Executive Independent Director | |
| K. L. Khurana | Non-Executive Independent Director | |
| A. Raghu Vasu | Non-Executive Independent Director |